CRSP vs. TWST

In the year-to-date period, CRSP achieves a -9.50% return, which is significantly higher than TWST's -33.68% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for CRISPR Therapeutics AG (CRSP) and Twist Bioscience Corporation (TWST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current CRSP Sharpe Ratio is -0.60, which is lower than the TWST Sharpe Ratio of -0.43. The chart below compares the historical Sharpe Ratios of CRSP and TWST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither CRSP nor TWST has paid dividends to shareholders.

The maximum CRSP drawdown since its inception was -85.11%, smaller than the maximum TWST drawdown of -94.48%. Use the drawdown chart below to compare losses from any high point for CRSP and TWST. For additional features, visit the drawdowns tool.

CRISPR Therapeutics AG (CRSP) and Twist Bioscience Corporation (TWST) have volatilities of 21.76% and 22.46%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between CRISPR Therapeutics AG and Twist Bioscience Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.